Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
about
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-term safety and survival ...... erapy for early breast cancer.
@en
Long-term safety and survival ...... erapy for early breast cancer.
@nl
type
label
Long-term safety and survival ...... erapy for early breast cancer.
@en
Long-term safety and survival ...... erapy for early breast cancer.
@nl
prefLabel
Long-term safety and survival ...... erapy for early breast cancer.
@en
Long-term safety and survival ...... erapy for early breast cancer.
@nl
P2093
P2860
P50
P1476
Long-term safety and survival ...... erapy for early breast cancer.
@en
P2093
Alexios Matikas
Barbro Linderholm
Elisabet Lidbrink
Hemming Johansson
Henrik Lindman
Jonas Bergh
Kenneth Villman
Lena Karlsson
Mats Hellström
Nils-Olof Bengtsson
P2860
P2888
P304
P356
10.1007/S10549-017-4599-4
P407
P577
2017-11-30T00:00:00Z